Taxotere Lawsuit Some Facts To Understand

Taxotere (docetaxel) is a chemotherapy drug sold by Sanofi-Aventis. It was originally approved by the U.S. Food and Drug Administration in 1996. Since then, the agency approved the drug to treat a variety of cancers. It is one of the most popular drugs used to treat breast cancer.

How Taxotere Is Given:

  • Taxotere is given through a vein (intravenously, IV)  
  • There is no pill form of Taxotere
  • Premedication with a corticosteroid pill starting a day prior to Taxotere infusion for 3 days is given to reduce the severity of fluid retention and allergic reactions. Your doctor will prescribe the exact regimen.
  • The amount of Taxotere that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated.  Your doctor will determine your dose and schedule.

All body hair is affected, including eyebrows, eyelashes and pubic hair. As a result of the hair loss side effects of Taxotere, several women are coming forward and filing lawsuits against Sanofi. One can  also check out  if you want to hire National Taxotere Hair Loss Attorneys .

Women who undergo cancer treatment expect that their hair might fall out, but are told that it will grow back a few months after therapy ends. If you are suffering   from permanent hair loss as a result of exposure to Taxotere, you may take some legal actions against Sanofi .

Permanent Hair Loss Linked To Taxotere

While chemotherapy is known to cause hair loss, most cases resolve in 3-6 months after the treatment is finished and hair completely regrows. Hair loss following chemotherapy is one of the most distressing side effects of treatment.

They also expect that, if a certain chemo drug presents an abnormally high risk for irreversible hair loss, that they will be informed of this side effect so that they can make an informed health care decision.

Leave a Reply

Your email address will not be published. Required fields are marked *